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Background: While enterococci resistant to multiple antimicrobials are spreading in hospitals worldwide, causing
urinary tract, wound and bloodstream infections, there is little published data on these infections from Africa.
Methods: We assessed the prevalence, susceptibility patterns, clinical outcome and genetic relatedness of
enterococcal isolates causing bloodstream infections in children in a tertiary hospital in Tanzania, as part of a
prospective cohort study of bloodstream infections among 1828 febrile children admitted consecutively from
August 2001 to August 2002.
Results: Enterococcal bacteraemia was identified in 2.1% (39/1828) of admissions, and in 15.3% (39/255) of cases of
culture-confirmed bloodstream infections. The case-fatality rate in children with Enterococcus faecalis septicaemia
(28.6%, 4/14) was not significantly different from those with Enterococcus faecium septicaemia (6.7%, 1/15, p = 0.12).
E. faecium isolates commonly had combined ampicillin-resistance and high-level gentamicin resistance (HLGR),
(9/17), while E. faecalis frequently displayed HLGR (6/15), but were ampicillin susceptible. None of the tested
enterococcal isolates displayed vancomycin resistance by Etest or PCR for vanA and vanB genes. Multi-locus
sequence-typing (MLST) showed that the majority of E. faecium (7/12) belonged to the hospital associated Bayesian
Analysis of Population Structure (BAPS) group 3–3. Pulsed-field gel electrophoresis (PFGE) indicated close genetic
relationship particularly among E. faecium isolates, but also among E. faecalis isolates. There was also correlation
between BAPS group and PFGE results. Risk factors for enterococcal bloodstream infection in univariate analysis
were hospital-acquired infection and clinical diagnosis of sepsis with unknown focus. In multivariate analysis, neonates
in general were relatively protected from enterococcal infection, while both prematurity and clinical sepsis were risk
factors. Malnutrition was a risk factor for enterococcal bloodstream infection among HIV negative children.
Conclusion: This is the first study to describe bloodstream infections caused by ampicillin-resistant HLGR E. faecium and
HLGR E. faecalis in Tanzania. The isolates of E. faecium and E. faecalis, respectively, showed high degrees of relatedness by
genotyping using PFGE. The commonly used treatment regimens at the hospital are insufficient for infections caused by
these microbes. The study results call for increased access to microbiological diagnostics to guide rational antibiotic use
in Tanzania.
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Enterococci are normal inhabitants of human and ani-
mal intestine [1-3]. They were previously considered in-
nocent commensal organisms as compared to more
virulent organisms, such as Streptococcus pyogenes and
Staphylococcus aureus. In recent years enterococci, first
Enterococcus faecalis [4] and more recently Enterococcus
faecium [5,6], have emerged as major pathogens causing
nosocomial infections, particularly urinary tract, wound
and bloodstream infections. Enterococci tend to cause
infections in immunocompromised hosts and seriously
ill patients and patients with indwelling devices, such as
catheters [7]. There is evidence that enterococci are a
significant cause of bacteraemia in people with HIV in-
fection [8]. Enterococci are intrinsically resistant to
cephalosporins [9-11] and have reduced susceptibility to
aminoglycosides [12]. Enterococci also have great ability
to acquire antimicrobial resistance through mutations
and exchange of genetic material [3]. High consumption
of cephalosporins tends to select for enterococci and
favour their spread in hospital settings [13-15]. Resist-
ance to anti-enterococcal first-line drugs such as ampicil-
lin and the combination ampicillin/gentamicin, commonly
used empirically for sepsis, is increasing rapidly [16,17].
Vancomycin-resistant enterococci (VRE) have spread glo-
bally [16] and have become a very important cause of
nosocomial infections. Treatment of VRE infections is
hampered by the fact that many isolates are resistant to
multiple other agents as well [18,19]. Typing of E. faecium
strains by multi-locus sequence typing (MLST) has identi-
fied hospital-adapted subpopulations, initially coined
clonal complex 17 (CC17), as being associated with ser-
ious infections and nosocomial outbreaks worldwide
[16,20-22]. Further analysis on the population genetics of
E. faecium indicated the existence of three hospital lineages
(17, 18, and 78), that group in two Bayesian Analysis of
Population Structure (BAPS) groups, BAPS 2–1 (lineage
78) and BAPS 3–3 (lineage 17 and 18) [23]. Recent whole
genome-based phylogeny suggests that these hospital-
lineages are all part of a single clade, called A1 [24].
Little is known about the role of enterococci in blood-
stream infections in East Africa, their resistance patterns,
and whether certain clonal complexes are associated with
more disease in this setting. However, carriage of high-
level gentamicin-resistant (HLGR) enterococci has been
described in Zimbabwe [25] and South Africa [26]. Out-
breaks of infections caused by VRE have been reported
from South Africa [27] and VRE are often found in milk,
beef, and chicken in Botswana [28].
The purpose of this study was to assess the prevalence,
resistance patterns, and genetic relatedness of enterococ-
cal isolates causing bloodstream infections in children at
Muhimbili National Hospital, Dar es Salaam, Tanzania,
and risk factors for such infections.Methods
The study took place from August 2001 to August 2002
at the Paediatric Department at Muhimbili National
Hospital, a tertiary referral hospital in Dar es Salaam,
Tanzania. A cohort of 1828 consecutive admissions of a
total of 1787 children presenting with clinical features of
systemic infection were included in the study as de-
scribed elsewhere [29]. The inclusion criteria were fever,
hypothermia and other signs and symptoms described in
the World Health Organization’s program for Integrated
Management of Childhood Illness (IMCI) [30], including
general danger signs such as convulsions, lethargy, inabil-
ity to drink or breastfeed, vomiting, and other signs of in-
fection, such as neck stiffness, bulging fontanelles, cough,
tachypnoea, difficulty breathing, chest in-drawings, nasal
flaring, grunting, diarrhoea, dehydration, ear or eye dis-
charge, lymphadenopathy, and, in neonates, signs of infec-
tion in the skin and umbilicus. The attending clinician
recorded patient data using a standardized case report
form. Medical records and departmental registries for ad-
missions, discharges and deaths were reviewed with the
purpose of quality-assuring the data.
The protocol was approved by The Research and Pub-
lications Committee of Muhimbili University College of
Health Sciences and by the National AIDS Control
Programme. Since the study subjects were young chil-
dren aged 0–7 years, the parents or other accompanying,
responsible family members were asked for written con-
sent on behalf of the patient. Written informed consent
was obtained before including the patient in the study
and before taking blood tests. In some circumstances, in
the case of critically ill patients, blood specimens were
taken based on verbal consent, since these investigations
are strongly recommended as routine investigations for
severely ill febrile children, and since it would be in-
appropriate to delay management of such patients due
to paperwork. The responsible family member was then
approached in retrospect for written consent to use
these specimens. The Tanzanian national language,
Kiswahili, was used for obtaining consent.
Blood specimens were examined for growth of bac-
teria, mycobacteria and fungi by the use of BACTEC™
MYCO/F Lytic culture vials. Isolates were identified by
standard microbiological methods as described in Mackie
& McCartney Practical Medical Microbiology [31]. E. fae-
calis and E. faecium species identification was confirmed
by polymerase chain reaction (PCR) of the ddl gene [32].
Susceptibility was tested by the disk diffusion method ac-
cording to the guidelines of the National Committee for
Clinical Laboratory Standards (NCCLS, now CLSI - Clin-
ical and Laboratory Standards Institute) [33] for doxycyc-
line and chloramphenicol. Testing for minimum inhibitory
concentration (MIC) was performed by Etest (BioMerieux,
Craponne, France, previously AB Biodisk, Solna, Sweden)
Aamodt et al. BMC Infectious Diseases  (2015) 15:107 Page 3 of 9for ampicillin, high-level gentamicin-resistance, vanco-
mycin, linezolid, and quinupristin-dalfopristin. Resistance
to ampicillin was defined as MIC ≥ 16 (mcg/ml) and high-
level gentamicin-resistance as MIC > 500 (mcg/ml) as
assessed by Etest. PCR for vanA and vanB genes was per-
formed to detect vancomycin resistance.
Genetic relatedness of the isolates was assessed by
pulsed field gel electrophoresis (PFGE). This was per-
formed on SmaI (Promega Corp, Madison, WI) digested
genomic DNA as previously described [34] and modified
by Dahl et al. [35]. The PFGE patterns were analysed
with Bionumerics, version 3.0 (Applied Maths, Kortrijk,
Belgium). The Dice coefficient of similarity was calculated,
and unweighted pair group method with arithmetic aver-
ages (UPMGA) was used for cluster analysis. Twelve E.
faecium isolates were also investigated by MLST. MLST
was carried out with a standard set of primers that amplify
the 7 genes included in the E. faecium MLST scheme [36].
Information on these loci, the latest set of primers, ampli-
fication conditions, and details of all isolates are available
on the MLST Web site (http://pubmlst.org/efaecium/).
Community-acquired (CA) infection was defined as
bloodstream infection (BSI) with growth of pathogenic
bacteria in a blood-culture obtained within the first
48 hours after admission [37]. A neonate who was born in
hospital within the last 10 days was considered as having
hospital-acquired (HA) infection. HIV testing was per-
formed by ELISA as previously described and confirmed
by PCR for children <18 months [29]. For the univariate
analysis, Chi-square test and student t-test was used to
compare proportions and means, respectively. Multivari-
ate analysis was performed by stepwise backwards logistic
regression with threshold p = 0.2 for removal from the
model and p = 0.05 for inclusion. Risk factors were re-
moved one-by-one starting with the least significant factor
until remaining with only factors significant to the level of
p < 0.2. Since only about half (n = 942) of the study partici-
pants consented to be HIV tested, and the many missing
values would affect the logistic regression model, we
present two different models; one where HIV status is re-
moved from the model (n = 1603), and one where HIV sta-
tus is locked in the model (n = 842). Statistical analysis
was performed in Stata 13 (Stata Corp, College Station,
Texas, US).
Results
Thirty-nine of 1828 cases (2.1%) had growth of entero-
coccal isolates in blood culture. The clinical presentation
of patients with enterococcal bacteraemia was assessed
as clinical sepsis without certain focus in 45% (n = 15),
pneumonia in 21% (n = 7), urinary tract infection in 11%
(n = 4), and non-specific infection without sepsis-symptoms
in 21% (n = 7), while six patients could not be evaluated
due to missing clinical information. Enterococcal isolatescontributed to 15.3% (39/255) of the total number of identi-
fied episodes of bacteraemia in the study, 17 caused by
E. faecium, 15 by E. faecalis and 7 by enterococcal isolates
that were not available for speciation. Since some patients
had more than one isolate of E. faecium, the total number
of E. faecium isolates was 21. Twenty-three percent (9/39)
of the patients had enterococci as part of a polymicrobial
infection, involving other enterococcal isolates as well as 2
isolates of Candida species, 3 klebsiellae isolates and single
isolates of Salmonella enteritidis, Staphylococcus aureus
and Streptococcus viridans. The majority of E. faecium bac-
teraemia episodes (10/17) were hospital-acquired, i.e.
obtained in blood-cultures taken ≥48 hours after admis-
sion, while the majority of E. faecalis bacteraemia epi-
sodes (10/15) were community-acquired.
The antimicrobial susceptibility of the isolates is
shown in Table 1. Nine of 17 E. faecium isolates showed
combined ampicillin-resistance and HLGR. Six of 15
E. faecalis isolates were HLGR, but none of these were
resistant to ampicillin. All except one of the HLGR iso-
lates were also resistant to chloramphenicol. The resist-
ant strains were recovered from different wards,
including the neonatal ward. All isolates were sensitive
to vancomycin by disk-diffusion testing and Etest, and
none of the 22 tested isolates were positive on PCR for
vanA or vanB genes.
Twenty-one isolates of E. faecium and 15 isolates of
E. faecalis were available for PFGE. The majority of the
E. faecium and E. faecalis isolates were closely related as
assessed visually from PFGE (Figure 1). From the figure
11/15 E. faecalis cluster at 72% similarity and 13/21
E. faecium at 80% similarity (Some duplicate strains are
analysed in the dendrogram, resulting in totals of 12/16
similarly clustering E. faecalis and 17/25 similarly clus-
tering E. faecium banding patterns). To assess whether
the E. faecium isolates belonged to previously described,
globally dispersed hospital subpopulations, MLST was
performed on 12 E. faecium isolates and identified 7 dif-
ferent sequence types (STs) of which ST132 (5 isolates)
and ST18 (2 isolates) were found in multiple isolate.
These two STs, involving 7/12 isolates belong to lineage-
18, which is contained in the global hospital-associated
BAPS group 3–3. In the current study, persons with
hospital-acquired infection accounted for 4 of 6 isolates
in BAPS group 3–3. All 5 isolates of ST132 came from
the same ward (neonatal ward). Isolates with ST125 and
ST169, belonging to BAPS 3–1, and ST170 and ST171
belonging to BAPS 2–3 are also evolutionary related.
Isolate 1064, ST178, belongs to BAPS 1, which is signifi-
cantly associated with human commensal isolates in the
community. Isolates with STs belonging to BAPS 3–3
were also related by PFGE. All isolates with STs belong-
ing to BAPS 3–3 as well as isolate 2118 (ST125) belong-
ing to BAPS 3–1 were ampicillin resistant, while the
Table 1 Antimicrobial susceptibility of enterococci causing bloodstream infection among febrile children admitted to
Muhimbili National Hospital
Antibiotic Susceptibility
E. faecium E. faecalis Enterococci
Antibiotic CA HA All CA HA All All
Etest
Ampicillin 25% 11% 19% 100% 100% 100% 53%
High-level Gentamicin 67% 33% 52% 56% 67% 60% 56%
Vancomycin* 100% 100% 100% 100% 100% 100% 100%
Linezolid 100% 100% 100% 100% 100% 100% 100%
Quinupristin-dalfopristin 100% 100% 100% 0% 17% 7% 61%
Disk-diffusion
Chloramphenicol 50% 11% 32% 38% 33% 36% 33%
Doxycycline 9% 0% 5% 25% 0% 14% 9%
*Confirmed by negative PCR for vanA and vanB genes.
CA = community-acquired, HA = hospital-acquired.
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isolates carried the esp gene.
Time in hospital from admission until blood cultures
were obtained was not significantly longer among pa-
tients with BSI caused by E. faecium (median 3 days,
range 0–10, p = 0.06) or E. faecalis (median 4 days, range
0–20, p = 0.56) compared to those with BSI caused by
other microbes (median 2 days, range 0–34).
Table 2 shows univariate and multivariate analysis of
risk factors for enterococcal BSI. HIV status was only
known for 51.5% (n = 942) of patients, among which
18.7% (n = 176) were positive. As including HIV status
in the multivariate analysis would eliminate close to half
of the observations, we present two different multivari-
ate models; one without HIV status (n = 1603 evaluable
patients) and one with HIV status locked in the model
(n = 842). Apart from factors shown in the table, all re-
corded clinical diagnoses and symptoms were assessed
as risk factors.
Hospital-acquired infection (i.e. positive blood-culture
drawn >48 hours after admission) was a risk factor for en-
terococcal BSI compared to community-acquired clinical
infections (i.e. positive blood-culture drawn <48 hours
after admission) in univariate analysis (Odds ratio (OR):
1.9, 95% confidence interval (95% CI): 1.01-3.61, p =
0.046), but did not remain a significant risk factor in
multivariate analysis (OR: 2.0, 95% CI: 0.96-4.00, p =
0.066) (Table 2). There was no difference in proportions of
hospital-acquired infection between enterococcal BSI com-
pared to patients with other culture-proven BSI (44%, 17/
39 vs 51%, 111/216, p = 0.37). Community-acquired and
hospital-acquired E. faecium isolates did not have different
rates of ampicillin-resistance (75% 9/12 vs 89%, 8/9, p =
0.42) or high-level gentamicin resistance (38%, 8/21 vs 53%,
8/15, p = 0.36).A clinical diagnosis of sepsis with unspecified focus
of infection was a borderline significant risk factor for
enterococcal infection in univariate analysis (OR: 2.0,
95% CI: 1.00-4.00, p = 0.050) and a significant risk fac-
tor in multivariate analysis (OR: 2.9, 95% CI: 1.36-6.20,
p = 0.006). In the multivariate analysis on the subset
with known HIV status, sepsis remained a significant
risk factor. Clinical diagnoses of urinary tract infection
or pneumonia were not significant risk factors.
Prematurity was a significant risk factor for enterococcal
bacteraemia in multivariate analysis (OR: 4.4, 95% CI:
1.06-18.1, p = 0.041), although this relationship was not
significant in univariate analysis. Being a neonate appeared
relatively protective in multivariate analysis (OR: 0.4, 95%
CI: 0.14-0.98, p = 0.046), although again this was not sig-
nificant in the univariate analysis. Within the cohort of ne-
onates (children < 1 month of age), enterococcal BSI
accounted for almost a quarter of BSI episodes in prema-
ture babies (23.1%, 3/13), and, despite the small numbers,
the premature babies had a significantly increased risk of
enterococcal BSI compared to babies born to term (5.8%
vs 1.4%, OR 4.3, 95% CI: 1.03-17.55, p = 0.045). Prematur-
ity remained a significant risk factor in the multivariate
analysis on the subset of children with known HIV status.
The proportion of malnourished children was 21% in
children with enterococcal BSI and 15% in controls, but
this difference was not significant, neither in the univari-
ate nor in the overall multivariate analysis. However, in
the multivariate analysis on patients with known HIV
status, malnutrition was indeed a significant risk factor
for enterococcal BSI (OR 3.7, 95% CI 1.24-11.28, p =
0.019). The selection of children with known HIV status
may have been skewed in the sense that malnourished
and HIV positive patients may share clinical features,
and thus more malnourished children may have been
Figure 1 Genetic relatedness of enterococcal isolates causing bloodstream infections in Tanzanian children. The dendrogram shows
genetic relatedness based on pulsed-field gel electrophoresis analysis on SmaI digested genomic DNA. Genetic relatedness was also assessed by
multi-locus sequence typing and corresponding Bayesian Analysis of Population Structure (BAPS) groups are indicated in the dendrogram.
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cohort of HIV negative children, malnourishment was a
statistically significant risk factor for enterococcal BSI
(6.6% (5/76) vs 2,3% (14/606), OR: 3.0, 95% CI: 1.04-
8.51, p = 0.042), while there was no such association in
HIV positive children (1.7% (1/60) vs 2.0% (2/100), OR:
0.83, 95% CI: 0.07-9.36, p = 0.881).
Altogether, HIV status was known for 51.5% (942/
1828) of the total number of admission during the study(corresponding to 51.0% of patients (911/1787), and for
59% (23/39) of those with enterococcal BSI. There was
no significant difference in HIV positivity rate between
patients with enterococcal BSI (13.0%, 3/23) and all
other patients with known HIV status (18.8%, 173/919,
p = 0.486), and neither compared to those with BSI of
other aetiologies (22.0%, 28/127, p = 0.33). Neither cephalo-
sporin use, nor other antibiotic use prior to obtaining
blood-culture, were significant risk factors for enterococcal
Table 2 Univariate and multivariate† analysis of risk factors for enterococcal bloodstream infection among febrile children admitted to Muhimbili National
Hospital (n = 1828)*
Univariate anlysis Multivariate analyses†
All patients with clinical
information (n = 1603)
All patients with known
HIV status (n = 842)
Variable Enterococci Others OR (95% CI) P OR (95% CI) P OR (95% CI) P
Neonate 28.2% (11/39) 29.3 (524/1789) 0.9 (0.47-1.92) 0.883 0.4 (0.14-0.98) 0.046 ‡g
Prematurity 9.1 (3/33) 3.2 (51/1570) 3.0 (0.88 - 10.08) 0.079 4.4 (1.06-18.1) 0.041 4.7 (1.19-18.8) 0.019
Male sex 61.5 (24/39) 55.4 (992/1789) 1.3 (0.67 - 2.47) 0.450 ‡e 2.9 (1.03-7.91) 0.043
Hospital acquired infection# 48.7 (19/39) 33.2 (594/1789) 1.9 (1.01 - 3.61) 0.046 2.0 (0.96– 4.00) 0.066 1.8 (0.73-4.29) 0.209
Antibiotic use before blood culture 66.7 (26/39) 57.0 (1020/1789) 1.5 (0.77 – 2.95) 0.231 ‡c ‡b
Cephalosporin use before blood culture 5.1 (2/39) 4.0% (71/1789) 1.3 (0.31 – 5.53) 0.715 ‡a ‡c
Diagnoses
Malnutrition 21.2 (7/33) 15.4 (241/1570) 1.5 (0.64 - 3.46) 0.360 ‡f 3.7 (1.24-11.28) 0.019
HIV infection 13.0 (3/23) 18.8 (173/919) 0.6 (0.19 – 2.20) 0.486 § 0.5 (0.14-2.04) 0.363§
Urinary tract infection 12.1% (4/33) 11.4% (179/1570) 1.1 (0.37- 3.08) 0.898 ‡b ‡a
Pneumonia 21.2% (7/33) 20.1% (315/1570) 1.1 (0.46- 2.49) 0.871 ‡d ‡e
Sepsis with unknown focus 45.5% (15/33) 29.4% (462/1570) 2.0 (1.00- 4.00) 0.050 2.9 (1.36-6.20) 0.006 2.6 (1.06-6.55) 0.037
Congenital heart disease 6.1% (2/33) 2.3% (36/1570) 2.7 (0.63- 11.93) 0.177 ‡g ‡d
Acute watery diarrhoea 9.1 (3/33) 21.8 (343/1570) 0.4 (0.11 - 1.18) 0.091 0.3 (0.09-1.07) 0.065 ‡f
OR = Odds ratio, 95% CI = 95% confidence interval, *There are varying numbers of patients evaluated for each risk factor because, among the 1828 study persons, we only have information on HIV status for n = 942
and sufficient clinical information for n = 1603. #Hospital acquired = blood culture taken >48 hours after admission †Multivariate analysis was performed by stepwise backwards logistic regression with threshold p = 0.2
for removal from the model and p = 0.05 for inclusion, ‡Risk factors were removed in a stepwise fashion in the sequence of ascending letters from “a” to “g”, §HIV was removed from the first logistic regression because
the many missing values would affect the model, HIV was locked in the second model although number of observations were reduced.
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multivariate analysis of the subset with known HIV status,
but not in univariate or overall multivariate analysis
(Table 2).
Clinical outcome was known for 89.3% (1632/1828) of
the admissions. Among those with known outcome, the
case-fatality rate in children with E. faecalis septicaemia
(28.6%, 4/14) was not significantly higher than for those
with E. faecium septicaemia (6.7%, 1/15, p = 0.12). Chil-
dren with enterococcal BSI received inappropriate
chemotherapy due to antimicrobial resistance in 44.1%
(15/39) of the cases, but this was not significantly differ-
ent from BSI due to other agents (41.6%, 77/185, p =
0.8). The case fatality rate was 20% (3/15) for enterococ-
cal BSI treated with inappropriate antibiotics, and 10%
(2/19) for those treated with appropriate antibiotics,
however, the numbers were small and the difference was
not statistically significant (p = 0.439). Among patients
with E. faecalis bacteraemia, two had concomitant mal-
aria parasitaemia detected on microscopy, both of whom
died. Among patients with E. faecium bacteraemia, one
had concomitant growth of S. aureus, two had Candida
species in blood culture, and two had concomitant mal-
aria parasitaemia, none of whom died.
Discussion
Recent studies from Tanzania have described entero-
cocci in urinary tract infections [38,39], but, to our
knowledge, there are no published clinical studies on en-
terococcal bloodstream infections from this country. Al-
though the data from the current study were collected
some years ago, the study provides insight in prevalence,
resistance patterns, and risk factors of enterococcal
bloodstream infections in Tanzania, confirming similar
trends as seen in Europe and the USA, and sets a bench-
mark for future studies. Surprisingly, we do not find that
prior use of cephalosporins or other antibiotic use is a
risk factor for enterococcal BSI in this study. This may
be due to small numbers.
Enterococci are a prevalent aetiology for bloodstream
infections in Tanzania, comprising 15.3% of the total num-
ber of identified episodes of bacteraemia in the current
study. Information on antimicrobial use was available for
85.2% (1557/1828) of admissions and at least two-thirds
(67.2%, 1046/1557) received antibiotics before blood-
culture was taken. This may have selected more resistant
clones in our study. All ampicillin-resistant HLGR E. fae-
cium isolates were susceptible to vancomycin, linezolid
and quinupristin/dalfopristin. All HLGR E. faecalis isolates
were sensitive to vancomycin, linezolid and ampicillin.
As expected, the majority of E. faecium isolates were
hospital-acquired, and hospital-acquired infection was a
significant risk factor for enterococcal infections in univar-
iate analysis. In accordance with other studies, mostisolates associated with hospital-acquired infections clus-
tered in BAPS group 3–3 based on MLST. The patient
with ST178/ BAPS 1, a BAPS group significantly associ-
ated with human commensals in the community, had a
clinical diagnosis of tuberculosis/pneumonia and anaemia.
A clinical diagnosis of sepsis, but not pneumonia and
urinary tract infection, was a significant risk factor for
enterococcal BSI. While neonates in general were not
particularly at risk, premature babies had significantly
increased risk of enterococcal BSI. Malnutrition was a
significant risk factor for enterococcal BSI in sub-
analysis of children with known HIV status (multivariate
analysis), particularly among those with known negative
HIV test (univariate analysis).
Among the 14 patients with E. faecium recovered from
blood culture (and known outcome) only one died, this
was a two months old boy with suspected meningitis
who was admitted with fever, convulsions and neck stiff-
ness. The isolate was resistant to ampicillin and chlor-
amphenicol, and high-level gentamicin-resistant. The
patient received antimicrobial treatment with penicillin
and chloramphenicol, to which the enterococcal isolate
was resistant. Chloramphenicol is largely abandoned in
developed countries due to the risk of aplastic anaemia,
although it has been used to treat VRE. Chlorampheni-
col is still widely used in Africa for the treatment of a
number of bacterial infections including meningitis and
typhoid fever. It was, however, uncertain whether the
E. faecium isolate was the cause of the meningitis, which
was thought to be the main diagnosis.
Among the patients with E. faecalis bacteraemia, four
died. Two of those who died had concomitant malaria
parasitaemia on microscopy, one of which received quin-
ine (for the other therapy was unknown). Two of them
had HLGR, including one of the patients with malaria
parasitaemia. The given antimicrobial therapy was known
for three of the patients, one of which received inappropri-
ate antibiotic treatment (chloramphenicol), and two of
which received at least one appropriate antibiotic (ampicil-
lin) and one inappropriate (gentamicin) for HLGR.
Conclusions
Consistent with global trends showing increasing im-
portance of E. faecium as a cause of human infections
relative to E. faecalis [22,40], our study found that more
than half of the enterococcal bloodstream infections
were caused by E. faecium in this hospital. This first
clinical study of enterococcal bloodstream infections
from Tanzania has identified septicaemia caused by
ampicillin-resistant and HLGR enterococci as common
nosocomial infections with a considerable case-fatality
rate. Premature babies and malnourished children, and
those with a clinical diagnosis of sepsis with unknown
focus appeared at particular risk. These infections
Aamodt et al. BMC Infectious Diseases  (2015) 15:107 Page 8 of 9constitute a therapeutic problem as the commonly used
treatment regimens at the hospital (ampicillin and gen-
tamicin or penicillin and chloramphenicol) are insuffi-
cient for infections caused by ampicillin-resistant
HLGR enterococci. Vancomycin is the empirical drug of
choice for proven E. faecium bloodstream infections.
However, in a resource-constrained setting such as
Tanzania, limited access to microbiological laboratories
and expensive second-line antimicrobials may render
such recommendations futile. Furthermore, escalating
empirical use of broad-spectrum antibiotics may be
ecologically detrimental in a setting where microbio-
logical laboratory services are scarce and patients rarely
get a bacteriologically confirmed diagnosis. In this con-
text, it is crucial to counteract further emergent anti-
biotic resistance by infection control measures and
prudent antibiotic use based on best available data from
surveillance activities, sentinel surveys, and, whenever
possible, microbiological diagnosis for the individual
patient.
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